SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is seeing intense retail and institutional focus as investors speculate on a short squeeze fueled by high short interest and anticipation of key trial results. The community is heavily divided, with long-term holders dismissing bearish concerns about trial design and the efficacy of Best Available Therapy as 'FUD' while bulls aggressively anticipate a potential buyout or major data-driven price move.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant volatility and trading volume as community members debate whether the asset is primed for a major short squeeze or trapped in a cycle of pump-and-dump behavior. Many are actively tracking support levels and liquidity shifts, while others express caution due to historical price swings and recent exchange delisting concerns.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is experiencing significant price volatility as the semiconductor sector grapples with broader tech market fluctuations and shifting investor sentiment toward AI hardware. The community is actively debating the stock's valuation, with many traders monitoring its ability to maintain key support levels amidst intense algorithmic trading activity and mixed macroeconomic signals.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing a strong recovery fueled by massive institutional accumulation and high trading volume during index rebalancing, further bolstered by reports of Michael Burry initiating bullish long-dated options positions. The community is actively debating whether this movement represents a sustainable trend reversal driven by fundamentally undervalued quality, or merely a short-term relief rally amidst broader sector rotation.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors weigh its pivot toward AI infrastructure and potential long-term fiber value against persistent sector concerns regarding competition from satellite-based connectivity. The market remains focused on the company's recent exclusion from the Dow Jones Industrial Average and ongoing adjustments to its debt structure as it navigates a challenging telecom landscape.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is seeing heightened community discussion as traders debate the stock's potential for a breakout following the elimination of the Pattern Day Trader (PDT) rule, which many believe will significantly boost trading volumes and revenue. While some investors are expressing frustration over the stock's struggle to hold key price levels compared to sector peers, others are highlighting institutional accumulation and strong underlying cash reserves as signs of a long-term undervalued opportunity.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending as investors focus on its critical role in providing on-site, behind-the-meter power solutions to solve the grid bottleneck caused by rapidly expanding AI data centers. Community discussion is split between excitement over the company's long-term utility in the AI infrastructure buildout and intense debate regarding its valuation, volatility, and technical price movements following index rebalancing.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is currently experiencing intense institutional rotation as investors weigh its aggressive share buyback program and AI-driven growth against broader sector sentiment shifts. While the stock has faced a historic streak of negative sessions, community discourse remains sharply divided between those viewing the current valuation as a generational entry point for long-term AI monetization and skeptics pointing to persistent bearish momentum.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors debate its transition from Bitcoin mining to a high-beta AI infrastructure play, driven by excitement over NVIDIA and Microsoft partnerships alongside intense scrutiny of recent management marketing expenditures. While bulls highlight the company's massive power pipeline and secular AI compute growth as a long-term catalyst, bears are vocal about ongoing dilution risks and the lack of immediate, large-scale hyperscaler deal announcements.

Re is an internet-native marketplace for insurance capital. It connects eligible capital providers with fully collateralized reinsurance activity conducted through licensed insurance entities. Blockchain infrastructure makes collateral, reserves, and selected operating data verifiable onchain. RE is the governance token of the Re Protocol. It governs protocol upgrades, technical permissions, committee formation, reporting standards, incentive policy, and governance procedures. Underwriting, claims, pricing, reserve decisions, and regulated operations remain with qualified professionals and licensed entities.

RE is trending as investors rally behind its role as a governance token for the decentralized Re Protocol, which aims to bring the global reinsurance market on-chain. The community is actively discussing its recent listings on major exchanges and its potential for growth, with many focused on its utility and limited circulating supply.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IBRX Japanese Insurance Reimbursement at Phase 2: A massive headline for your shares is that once a drug receives Conditional Early Approval in Japan, it is eligible for National Health Insurance reimbursement. This means the revenue &quot;Gush&quot; begins immediately upon Phase 2 completion, rather than waiting years for a Phase 3 &quot;Full&quot; approval.
• The 7-Year Safety Window: Under the CEA, ImmunityBio can sell Anktiva and CAR-NK for up to 7 years while they finalize the Phase 3 data. This effectively turns the Japanese population of 125 million into a revenue-generating Phase 3 trial.
• Bypassing &quot;Drug Loss&quot;: The Japanese Ministry of Health (MHLW) is desperate to solve &quot;drug loss&quot; (the lack of new medicines in Japan). They are actively inviting companies like ImmunityBio that have Sovereign data from places like Saudi Arabia to apply using the Phase 2 CEA framework.

BeautifulBiosInGreen

John Mack

zickzack

S Olsen

Aussie Taco Whisperer

reene

cyberInvest

Jkane

Wayne

Rick Abbey

Raj Rao

Bhav

Agnes Garve

Ulaughing

Kenneth Orthner

Rob Mazzetti

Ostseemann

Mr Iain Wylie

Sheldon

Jeffrey Park

Jeffrey Ponn

StockTwits for iOS

ImmunityBio Inc

 Japanese Insurance Reimbursement at Phase 2: A massive headline for your shares is that once a drug receives Conditional Early Approval in Japan, it is eligible for National Health Insurance reimbursement. This means the revenue "Gush" begins immediately upon Phase 2 completion, rather than waiting years for a Phase 3 "Full" approval.
• The 7-Year Safety Window: Under the CEA, ImmunityBio can sell Anktiva and CAR-NK for up to 7 years while they finalize the Phase 3 data. This effectively turns the Japanese population of 125 million into a revenue-generating Phase 3 trial.
• Bypassing "Drug Loss": The Japanese Ministry of Health (MHLW) is desperate to solve "drug loss" (the lack of new medicines in Japan). They are actively inviting companies like ImmunityBio that have Sovereign data from places like Saudi Arabia to apply using the Phase 2 CEA framework.

Paul Silberberg

@oceanviewhi have they started a phase 2 study in Japan? Or are they going with the studies already out there? Secondly, how big is the Japanese market?

StockTwits For Android 

 have they started a phase 2 study in Japan? Or are they going with the studies already out there? Secondly, how big is the Japanese market?